Skip to main content

Table 1 The correlation of the level of TUBA1C expression with the clinical features of lung adenocarcinoma

From: Prognostic biomarker TUBA1C is correlated to immune cell infiltration in the tumor microenvironment of lung adenocarcinoma

Characteristics

TUBA1C (%)

p‐value

Low

High

n

149

241

 

Age (years)

  

0.287

 ≤ 60

53 (35.6)

99 (41.1)

 > 60

96 (64.4)

142 (58.9)

 

Sex

  

0.452

 Female

60 (40.3)

87 (36.1)

 Male

89 (59.7)

154 (63.9)

 

Smoke

  

0.511

 No

123 (82.6)

192 (79.7)

 Yes

26 (17.4)

49 (20.3)

 

Size

  

0.093

 ≤ 3 cm

92 (61.7)

127 (52.9)

 > 3 cm

57 (38.3)

113 (47.1)

 

Histologic subtype

  

0.454

 Lepidic

2 (1.3)

10 (4.1)

 Acinar

59 (39.6)

100 (41.5)

 

 Papillary

13 (8.7)

22 (9.1)

 

 Micropapillary

3 (2.0)

8 (3.3)

 

 Solid

72 (48.3)

101 (41.9)

 

Lymph node metastasis

  

0.754

 No

83 (55.7)

130 (53.9)

 Yes

66 (44.3)

111 (46.1)

TNM

  

1

 I + II

107 (71.8)

174 (72.2)

 III + IV

42 (28.2)

67 (27.8)

 

VPI

  

0.758

 No

131 (87.9)

209 (86.7)

 Yes

18 (12.1)

32 (13.3)